NYMX - Nymox Pharmaceutical Corporation
| Previous Close | 2.4700 |
| Open | 2.5000 |
| Bid | 2.50 x 1400 |
| Ask | 3.14 x 800 |
| Day's Range | 2.5000 - 2.7200 |
| 52 Week Range | 1.2500 - 4.6000 |
| Volume | 101,919 |
| Avg. Volume | 90,513 |
| Market Cap | 172.678M |
| Beta (3Y Monthly) | 2.22 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.19 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 10.25 |
- Simply Wall St.•17 days ago
Does The Nymox Pharmaceutical Corporation (NASDAQ:NYMX) Share Price Fall With The Market?
If you own shares in Nymox Pharmaceutical Corporation (NASDAQ:NYMX) then it's worth thinking about how it contributes to the volatility of your portfolio, overall. In finance, Beta is a measure Read More...
- GlobeNewswire•last month
New Peer Review Article Entitled “Efficacy and safety of fexapotide triflutate in outpatient medical treatment of male lower urinary tract symptoms associated with benign prostatic hyperplasia” Published in Therapeutic Advances in Urology
HASBROUCK HEIGHTS, N.J., Jan. 15, 2019 -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) reports today that a new peer review article has been published in Therapeutic.
- GlobeNewswire•2 months ago
2018: A Year of Achievements for NYMOX
HASBROUCK HEIGHTS, N.J., Dec. 19, 2018 -- Following the Nymox (NASDAQ: NYMX) Annual General Meeting yesterday (December 18, 2018), Nymox management discussed many significant.
- Simply Wall St.•2 months ago
Are Insiders Selling Nymox Pharmaceutical Corporation (NASDAQ:NYMX) Stock?
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. On the other hand, we'd be remiss not to mention Read More...
- Associated Press•3 months ago
Nymox: 3Q Earnings Snapshot
The St. Laurent, Quebec-based company said it had a loss of 5 cents per share. The biopharmaceutical company posted revenue of $40,000 in the period. In the final minutes of trading on Tuesday, the company's ...
- Associated Press•6 months ago
Nymox: 2Q Earnings Snapshot
On a per-share basis, the St. Laurent, Quebec-based company said it had a loss of 4 cents. The biopharmaceutical company posted revenue of $88,000 in the period. In the final minutes of trading on Monday, ...
- Simply Wall St.•10 months ago
What You Must Know About Nymox Pharmaceutical Corporation’s (NASDAQ:NYMX) Major Investors
In this article, I’m going to take a look at Nymox Pharmaceutical Corporation’s (NASDAQ:NYMX) latest ownership structure, a non-fundamental factor which is important, but remains a less discussed subject amongRead More...
- Simply Wall St.•10 months ago
Should You Worry About Nymox Pharmaceutical Corporation’s (NASDAQ:NYMX) CEO Pay?
Leading Nymox Pharmaceutical Corporation (NASDAQ:NYMX) as the CEO, Paul Averback took the company to a valuation of US$236.27M. Recognizing whether CEO incentives are aligned with shareholders is a crucial partRead More...
- Simply Wall St.•11 months ago
Should You Have Nymox Pharmaceutical Corporation’s (NASDAQ:NYMX) In Your Portfolio?
For Nymox Pharmaceutical Corporation’s (NASDAQ:NYMX) shareholders, and also potential investors in the stock, understanding how the stock’s risk and return characteristics can impact your portfolio is important. NYMX is exposedRead More...
- Simply Wall St.•last year
Interested In Nymox Pharmaceutical Corporation (NASDAQ:NYMX)? Here’s What Its Recent Performance Looks Like
Today I will take a look at Nymox Pharmaceutical Corporation’s (NASDAQ:NYMX) most recent earnings update (30 September 2017) and compare these latest figures against its performance over the past fewRead More...
